Speakers

Expand/Collapse

Nathan Magarvey
Founder
Adapsyn Bioscience

Nigel Titford
CEO
Biogaia Pharma

Adrien Nivoliez
CEO
Biose Industrie

Assaf Oron
Chief Business Officer
BiomX

Chris Reyes
Co-Founder & CEO
Bloom Science

Jeffrey Heiser
Director Microbiology
Boston Analytical

Helena Cowley
CEO
Captozyme

Mark Pimentel MD
Director of MAST Program
Cedars-Sinai

Ben Bradley
Head of Partnerships & Licensing
CHAIN Biotech

John Colson
Director of Operations
ClostraBio

Greg Mckenzie
Chief Scientific Officer
ConsortiaTX

Nur Hasan
Chief Scientific Officer
CosmosID

Dan Knights
CEO
CoreBiome

Gerard Honig
Translational Research Manager
Crohn’s & Colitis Foundation

Julia Cope
Director of Scientific Operations
Diversigen

Mark Smith
CEO
Finch Therapeutics Group

Ulrich Thienel
Chief Medical Officer
Finch Therapeutics Group

Kris Piper
VP Regulatory Affairs
Finch Therapeutics Group

Bharat Dixit
VP Bioprocess & Analytical Development
Finch Therapeutics Group

Daniel van der Lelie
Chief Scientific Officer
Gusto Global

Esi Lamouse-Smith
Director - Early Development Translational Medicine in Immunology
Janssen Pharmaceuticals

Ling-Yang Hao
Associate Director
Janssen Pharmaceuticals

Karen Crawford
President
List Laboratories

Tina Chritensen-Ram
Quality Manager
LuinaBio

Mark Wilson
President & CEO
MatriSys Bioscience

Lynn Bry MD
Director
Massachusetts Host-Microbiome Center

Malcolm Kendall
CEO
Microbiome Insights

Mike Romanos
CEO
Microbiotica

Trevor Lawley
Chief Scientific Officer
Microbiotica

Julius Goepp
CEO
Scaled Microbiomics

Herwig Bachmann
Group Leader Fermentation
NIZO

Wes Whitaker
Co-Founder & CEO
Novome Biotechnologies

Liz Shepherd
Co-Founder
Novome Biotechnologies

Massimo Marzorati
CEO
ProDigest

Sam Possemiers
Managing Director
ProDigest

Mike Frodsham
Pharmaceutical Development Manager
Quay Pharma

Matthew Henn
EVP Microbiome R&D
Seres Therapeutics

Jim Weston
SVP Regulatory Affairs
Seres Therapeutics

Jennifer Wortman
Senior Director, Bioinformatics
Seres Therapeutics

Henry Rath
SVP Corporate Development
Seres Therapeutics

Nikole Kimes
Founder & Chief Scientific Officer
Siolta Therapeutics

Gregory Lambert
CEO
TargEDys

Cathryn Nagler
Bunning Food Allergy Professor
University of Chicago

Rita Colwell
Distinguished University Professor
University of Maryland

Alexander Khoruts MD
Medical Director
University of Minnesota Microbiota Therapeutics

Colleen Cutcliffe
Co-Founder & CEO
Whole Biome

Andrew Goodman
Associate Professor
Yale University

Bernat Olle
CEO
Vedanta Biosciences

Ross Youngs
CEO & Founder
Biosortia Pharmaceuticals

Suguna Rachakonda
Senior Director, Product Development
Cleveland Clinic

Romain Daillere
Co-Founder & Head of Preclinical Research
EverImmune

Dario Gutierrez
Head of Investigational Biology
Merck ESC

Daniel van der Lelie
Chief Scientific Officer
Gusto Global

Fyza Shaikh
Postdoctoral Fellow
John Hopkins Hospital

Ashwin Ananthakrishnan MD
Associate Professor of Medicine
Massachusetts General Hospital

Edward Burd
Head of Regulatory Affairs
Rebiotix

Matt Martin
Microbiome Lead Technology Commercialization
University of Chicago

Speaker Invited

FDA

David Cook
EVP & Chief Scientific Officer
Seres Therapeutics

Thomas J. DesRosier
Chief Legal Officer & Secretary
Seres Therapeutics

Glennda Smithson
Director, Translational Biomarker Research (Immunology)
Takeda

Eric Shaff
CEO
Seres Therapeutics

Alison Lawton
CEO
Kaleido Biosciences

Tuval Ben-Yehezkel
CEO
Loop Genomics

Katharine Knobil MD
Chief Medical Officer & Head of R&D
Kaleido Biosciences

Susan Stewart
SVP, Regulatory Affairs & Quality
Kaleido Biosciences

James McIlroy
Founder & Chief Business Officer
Enterobiotix

Lothar Steidler
Chief Technology Officer
ActoBio Therapeutics

Stacy Burns-Guydish
VP, Biotherapeutics Development & Manufacturing
List Laboratories

Ken Blount
CSO
Rebiotix